II. Indications
- See NSAID
 - FDA approved indications
- Rheumatoid Arthritis
 - Osteoarthritis
 - Mild to moderate pain
 - Primary Dysmenorrhea
 
 - Off-Label (Non-FDA approved) Indications
 
III. Contraindications
- See NSAID
 
IV. Mechanism
V. Medications
- Ketoprofen (Orudis) Immediate Release Capsules: 25 mg, 50 mg, 75 mg
 - Ketoprofen (Orudis) Extended Release Capsules: 200 mg
 
VI. Dosing: Adult
- Immediate Release
- Arthritis (RA, OA): 75 mg orally three times daily (or 50 mg orally every 6 hours)
 - Mild to moderate pain (including Dysmenorrhea): 25 to 50 mg orally every 6 to 8 hours
 
 - Extended-Release
- Arthritis (RA, OA): 200 mg orally daily
 
 
VII. Dosing: Child
- 
                          Juvenile Rheumatoid Arthritis (not FDA approved)
- Start 100 to 200 mg/m2/day in divided doses 3 to 4 times daily
 - Maximum: 320 mg/day
 
 
VIII. Adverse Effects
- See NSAID
 
IX. Safety
X. Efficacy
- Ketoprofen 25 mg comparable to Ibuprofen 400 mg
 - Ketoprofen 50 mg more potent than Tylenol #3
 
XI. Resources
- Ketoprofen Immediate Release (DailyMed)
 - Ketoprofen Extended Release (DailyMed)
 
XII. References
- Hamilton (2020) Tarascon Pocket Pharmacopoeia